2025-04-13 - Analysis Report
## Rivian Automotive Inc (RIVN) Stock Review

**0. Key Figures Summary:**

* **Cumulative Return (RIVN):** -35.7%
* **Cumulative Return (VOO):** 9.7%
* **Return Difference (RIVN vs VOO):** -45.4%
* **Relative Divergence:** 35.2% (Indicates RIVN underperformed VOO significantly, but within the historical range of divergence)
* **Current Price:** $11.47

**1. Performance Comparison and Company Overview:**

Rivian Automotive Inc is an American electric vehicle maker.  The provided data shows RIVN significantly underperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return of -35.7% compared to VOO's 9.7%. The -45.4% difference represents a substantial underperformance.  The relative divergence of 35.2% places this underperformance within the historical range, but still highlights significant losses relative to the market.


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | -2.0% | 76.0% | -16.0% | 0.0 | 26.5 |
| 2022-2024  | 20.0% | 76.0% | -4.0% | 0.0 | 15.0 |
| 2023-2025  | 17.0% | 99.9% | -0.0 | 0.0 | 13.0 |

The alpha consistently shows negative values, indicating underperformance compared to the benchmark.  The beta is close to zero across all periods, suggesting low correlation with the overall market.  The market capitalization (Cap(B)) has significantly decreased. The high Maximum Drawdown (MDD) values highlight significant volatility and risk.


**2. Recent Price Movement:**

* **Closing Price:** $11.47
* **5-day Moving Average:** $11.34
* **20-day Moving Average:** $11.79
* **60-day Moving Average:** $12.18

The price is below all three moving averages, suggesting a downtrend.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **RSI:** 44.54 (Slightly below neutral; not oversold)
* **PPO:** -0.46 (Negative, indicating bearish momentum)
* **Relative Strength Divergence (20-day):** -12.5% (Short-term bearish divergence)
* **Expected Return (2+ years):** -64.7% (Significantly below the S&P 500; indicating significant potential losses)


The recent price increase of $0.09 is relatively small and doesn't indicate a significant reversal. The technical indicators, coupled with the negative expected return, suggest a bearish outlook.  The high MRI confirms high market risk.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2024-11-07 | -1.08 | $0.87 B     |
| 2024-08-06 | -1.46 | $1.16 B     |
| 2024-05-07 | -1.48 | $1.20 B     |
| 2023-11-07 | -1.44 | $1.34 B     |
| 2024-11-07 | -1.44 | $1.34 B     | *(Duplicate Entry)*


Rivian continues to report negative EPS, indicating ongoing losses.  Revenue fluctuates, showing no clear upward trend.  The duplicate entry for 2024-11-07 needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.73B | 9.80% |
| 2024-09-30 | $0.87B | -44.85% |
| 2024-06-30 | $1.16B | -38.95% |
| 2024-03-31 | $1.20B | -43.77% |
| 2023-12-31 | $1.31B | -46.08% |


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $6.56B | -11.33% |
| 2024-09-30 | $5.90B | -18.65% |
| 2024-06-30 | $6.82B | -21.37% |
| 2024-03-31 | $8.07B | -17.92% |
| 2023-12-31 | $9.14B | -16.64% |


The financial data reveals substantial losses and negative profit margins, indicating the company is not yet profitable.  While revenue increased in Q4 2024, profit margins remain negative, and ROE consistently shows negative returns on equity.


**6. Overall Analysis:**

Rivian's stock performance is currently weak, significantly underperforming the S&P 500.  The company is not yet profitable, and financial indicators show ongoing losses and high risk.  Technical indicators suggest a bearish trend.  While a long-term investment *could* potentially benefit from future growth, the substantial negative expected return and high risk profile present significant concerns.  A thorough investigation into the causes of underperformance and the company's future prospects is crucial before considering any investment.  The duplicate entry in the earnings data requires clarification.
